Simon Sinclair
Förmögenhet: 1 367 $ per 2026-06-30
Förmögenhet: 1 367 $ per 2026-06-30
Simon Sinclair is currently Chairman at Reckitt Global Hygeine Institute, Director at Livingstone Global Ltd., Non-Executive Director at Renovos Biologics Ltd. since 2013, and Chief Medical Officer at Ondine Biomedical, Inc. since 2024.
Former roles include Director at DePuy International Ltd., Senior Director-Global Trial Optimization at Merck & Co., Inc. from 2008 to 2011, Director-International Clinical at Johnson & Johnson Medical Devices Cos.
from 2015 to 2018, Non-Executive Director at Coiled Therapeutics Plc from 2022 to 2026, Chief Safety Officer at Reckitt & Sons Ltd., and Chief Safety Officer at Reckitt Benckiser Group Plc from 2020 to 2023.
Education includes a doctorate from the University of Cambridge and an undergraduate degree from King's College London.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-06-27 | 10 843 ( 0 % ) | 1 367 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| ONDINE BIOMEDICAL INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-06-01 |
Renovos Biologics Ltd.
Renovos Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in regenerative medicine technologies | Direktör/Styrelseledamot | 2013-03-01 |
Livingstone Global Ltd. | Direktör/Styrelseledamot | - |
Reckitt Global Hygeine Institute | Ordförande | - |
| Företag | Position | Slut |
|---|---|---|
| ROQT THER | Direktör/Styrelseledamot | 2026-03-27 |
| RECKITT BENCKISER GROUP PLC | Företagsledare/Principal | 2023-05-01 |
Johnson & Johnson Medical Devices Cos.
Johnson & Johnson Medical Devices Cos. Medical SpecialtiesHealth Technology Manufactures medical devices | Företagsledare/Principal | 2018-08-01 |
| MERCK & CO., INC. | Företagsledare/Principal | 2011-02-01 |
DePuy International Ltd.
DePuy International Ltd. Medical SpecialtiesHealth Technology Engages in manufacture of medical and dental instruments and supplies | Direktör/Styrelseledamot | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 12 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Ondine Biomedical, Inc.
Ondine Biomedical, Inc. BiotechnologyHealth Technology Engages in the development of non-antibiotic therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections | Health Technology |
Reckitt Benckiser Group Plc
Reckitt Benckiser Group Plc Household/Personal CareConsumer Non-Durables Manufactures and markets household cleaning, health and nutrition products | Consumer Non-Durables |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reckitt & Sons Ltd.
Reckitt & Sons Ltd. Financial ConglomeratesFinance Provides financial services | Finance |
DePuy International Ltd.
DePuy International Ltd. Medical SpecialtiesHealth Technology Engages in manufacture of medical and dental instruments and supplies | Health Technology |
Renovos Biologics Ltd.
Renovos Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in regenerative medicine technologies | Commercial Services |
Roquefort Therapeutics Plc
Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
Johnson & Johnson Medical Devices Cos.
Johnson & Johnson Medical Devices Cos. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Livingstone Global Ltd. | |
Reckitt Global Hygeine Institute |
Välj din utgåva
All finansiell information anpassad till den nationella nivån